EyeRegenMed
New Member
- Joined
- Apr 25, 2012
- Messages
- 3
- Reaction score
- 0
ARVO 2012 starts this weekend.
I am particularly interested in developments in ocular tissue-engineering and regenerative ophthalmology. As such, I started a twitter account to cover new developments in this field: @EyeRegenMed
Follow my feed if your interested in the topic or just follow #ARVO2012 for all shared experiences from the conference.
If you are wondering what constitutes regenerative ophthalmology, I would like to direct you to this recent Lancet article that describes the preliminary results of sub-retinal transplantation of hECS-derived RPE cell in patients with Stargardt's Macular Dystrophy and Dry Age-Related Macular Degeneration.
I am particularly interested in developments in ocular tissue-engineering and regenerative ophthalmology. As such, I started a twitter account to cover new developments in this field: @EyeRegenMed
Follow my feed if your interested in the topic or just follow #ARVO2012 for all shared experiences from the conference.
If you are wondering what constitutes regenerative ophthalmology, I would like to direct you to this recent Lancet article that describes the preliminary results of sub-retinal transplantation of hECS-derived RPE cell in patients with Stargardt's Macular Dystrophy and Dry Age-Related Macular Degeneration.